anastrozole has been researched along with Dermatitis Medicamentosa in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " We report an unusual case of urticarial vasculitis following the aromatase inhibitor anastrozole that localised to the unilateral trunk and mastectomy scar, and review the literature on the cutaneous adverse effects of hormonal therapy for breast cancer." | 8.90 | Cutaneous adverse effects of hormonal adjuvant therapy for breast cancer: a case of localised urticarial vasculitis following anastrozole therapy and a review of the literature. ( Bock, VL; Friedlander, M; Kossard, S; Waring, D; Wood, GK, 2014) |
| " Anastrozole, a nonselective aromatase inhibitor used in breast cancer management has been associated with different cutaneous side effects, of which EM is rarely seen and usually in a minor or major form with typical target lesions." | 8.31 | Segmental Erythema Multiforme: An Unusual Drug Reaction to Anastrozole. ( Buljan, M; Filipović, N; Poduje, S; Vučić, M; Vujević, L, 2023) |
| " We report an unusual case of urticarial vasculitis following the aromatase inhibitor anastrozole that localised to the unilateral trunk and mastectomy scar, and review the literature on the cutaneous adverse effects of hormonal therapy for breast cancer." | 4.90 | Cutaneous adverse effects of hormonal adjuvant therapy for breast cancer: a case of localised urticarial vasculitis following anastrozole therapy and a review of the literature. ( Bock, VL; Friedlander, M; Kossard, S; Waring, D; Wood, GK, 2014) |
| " Anastrozole, a nonselective aromatase inhibitor used in breast cancer management has been associated with different cutaneous side effects, of which EM is rarely seen and usually in a minor or major form with typical target lesions." | 4.31 | Segmental Erythema Multiforme: An Unusual Drug Reaction to Anastrozole. ( Buljan, M; Filipović, N; Poduje, S; Vučić, M; Vujević, L, 2023) |
| "Anastrozole, a selective nonsteroidal aromatase inhibitor is widely used as an adjuvant therapy for postmenopausal women with early hormone-sensitive breast cancer." | 3.75 | Drug-induced pruritic micropapular eruption: anastrozole, a commonly used aromatase inhibitor. ( Bremec, T; Demsar, J; Luzar, B; Pavlović, MD, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Poduje, S | 1 |
| Vujević, L | 1 |
| Filipović, N | 1 |
| Vučić, M | 1 |
| Buljan, M | 1 |
| Bock, VL | 1 |
| Friedlander, M | 1 |
| Waring, D | 1 |
| Kossard, S | 1 |
| Wood, GK | 1 |
| Marchand, A | 1 |
| Georgin-Mège, M | 1 |
| Cellier, P | 1 |
| Martin, L | 1 |
| Avenel-Audran, M | 1 |
| Le Corre, Y | 1 |
| Bremec, T | 1 |
| Demsar, J | 1 |
| Luzar, B | 1 |
| Pavlović, MD | 1 |
| Potter, JE | 1 |
| Moore, KA | 1 |
1 review available for anastrozole and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Cutaneous adverse effects of hormonal adjuvant therapy for breast cancer: a case of localised urticarial vasculitis following anastrozole therapy and a review of the literature.
Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Lobular; Chemothera | 2014 |
4 other studies available for anastrozole and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Segmental Erythema Multiforme: An Unusual Drug Reaction to Anastrozole.
Topics: Anastrozole; Aromatase Inhibitors; Breast Neoplasms; Drug Eruptions; Erythema Multiforme; Female; Hu | 2023 |
Exemestane-induced radiation recall dermatitis and morbilliform rash.
Topics: Aged; Anastrozole; Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Arthralgia; Carcinom | 2016 |
Drug-induced pruritic micropapular eruption: anastrozole, a commonly used aromatase inhibitor.
Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Combined | 2009 |
Lichen sclerosus in a breast cancer survivor on an aromatase inhibitor: a case report.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clobetasol; Dr | 2013 |